Murugabaskar Balan

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape”.

A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape

Cancers(2020)10.3390/cancers12071782

N/A

0DataRank · unranked

21 citations

Samik Chakraborty, Simran Mahanta, Selina Banerjee, Murugabaskar Balan, Soumitro Pal +1 more

Metabolic reprogramming in renal cancer: Events of a metabolic disease

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2021)10.1016/j.bbcan.2021.188559

N/A

0DataRank · unranked

224 citations

Murugabaskar Balan, Akash Sabarwal, Toni K. Choueiri, Soumitro Pal, Samik Chakraborty

A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation

Carcinogenesis(2021)10.1093/carcin/bgab126

N/A

0DataRank · unranked

15 citations

Johannes Wedel, Kaifeng Liu, David Zurakowski, Samik Chakraborty, Evelyn Flynn +4 more

A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress

Redox Biology(2023)10.1016/j.redox.2023.102945

N/A

0DataRank · unranked

25 citations

Murugabaskar Balan, Yuzuru Sasamoto, Akash Sabarwal, Soumitro Pal, Laxminarayan Rawat

Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress

Cancer Letters(2025)10.1016/j.canlet.2025.217984

N/A

0DataRank · unranked

3 citations

Marc Machaalani, Laxminarayan Rawat, Johannes Wedel, Saba Tabasum, Yuzuru Sasamoto +14 more